1. Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Issue 28 (1st October 2021) Authors: Moskowitz, Alison J.; Shah, Gunjan; Schöder, Heiko; Ganesan, Nivetha; Drill, Esther; Hancock, Helen; Davey, Theresa; Perez, Leslie; Ryu, Sunyoung; Sohail, Samia; Santarosa, Alayna; Galasso, Natasha; Neuman, Rachel; Liotta, Brielle; Blouin, William; Kumar, Anita; Lahoud, Oscar; Batlevi, Connie L.;... Journal: Journal of clinical oncology Issue: Volume 39:Issue 28(2021) Page Start: 3109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗